Ertugliflozin | Interleukin Related interleukin-related.com

Product Name :
Ertugliflozin

Search keywords :
Ertugliflozin L-pyroglutamic acid

drugId :
null

Target Vo:
Sodium/glucose cotransporter 2

Target Vo Short Name :
SGLT2

Moa_Name:
Sodium/glucose cotransporter 2 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Merck Sharp & Dohme Bv

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:
Hepatic Insufficiency

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Andecaliximab Technical Information
Vandortuzumab Cancer
NK1R Antibody: NK1R Antibody is an unconjugated, approximately 48 kDa, rabbit-derived, anti-NK1R polyclonal antibody. NK1R Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, rat, guinea pig, and predicted: mouse, dog, pig, cow, horse background without labeling.

Author: Interleukin Related

Related Posts